NEW YORK (Reuters) – Mylan N.V.’s (MYL.O) emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment’s manufacturer said on Friday. EpiPens deliver potentially lifesaving doses of the g... More »
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker... More »
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo Generic drugmaker Mylan NV said on Friday that its manufacturi... More »
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo The U.S. Senate Judiciary Committee urged federal antitrust re... More »
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo Three members of the U.S. Senate Judiciary Committee, ahead of... More »
